Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iu E Livergant

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Meditsinskaia Radiologiia|December 1, 1976
[Assessment of thyroid gland function using 125I during treatment of thyrotoxicosis with 131I]Iu E Livergant
Sovetskaia Meditsina|December 1, 1973
[Clinical importance of radioimmunological analysis of blood insulin in diabetes mellitus]Iu E Livergant, K I Krupchitskaia
Voprosy Okhrany Materinstva I Detstva|October 1, 1974
[Blood content of immunoreactive insulin in children and adolescents with obesity]Iu E Livergant, N V Dudenko, K I Krupchitskaia
Problemy Endokrinologii|May 1, 1970
[Some characteristics of sulfhydryl (SH) group levels in serum and thyroid tissue of patients with diffuse toxic goiter]Iu E Livergant, V D Semenov, N G Tsarikovskaia
Meditsinskaia Radiologiia|January 1, 1977
[Effectiveness of the therapeutic use of 125I in diffuse toxic goiter]Iu E Livergant, E D Chebotareva, L N Polishchuk
Meditsinskaia Radiologiia|October 1, 1978
[Cellular immunity indices after radioiodine therapy of thyrotoxicosis]Iu E Livergant, T P Iakimova, V A Duma, et al.
Voprosy Onkologii|January 1, 1979
[State of hypophyseal thyrotropic function in the complex treatment of thyroid cancer]V I Ivanitskaia, A F Vladimirova, Iu E Livergant, et al.
Laboratornoe Delo|January 1, 1978
[Increasing the sensitivity of the radioimmunological determination of thyrotropin by means of blood plasma concentration]Iu E Livergant, A F Vladimirova, I N Lozinskaia, et al.
Vrachebnoe Delo|December 1, 1985
[Central hemodynamics in dust-induced bronchitis in workers in the machine-building industry]S I Rozdil'skiĭ, Iu E Livergant, A I Kleĭner, et al.
Vrachebnoe Delo|December 1, 1975
[Glucose tolerance and content of immunoreactive insulin in patients with ischemic heart disease]Iu E Livergant, V G Teslenko, S V Lebedev, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Meditsinskaia Radiologiia|December 1, 1976
[Assessment of thyroid gland function using 125I during treatment of thyrotoxicosis with 131I]Iu E Livergant
Sovetskaia Meditsina|December 1, 1973
[Clinical importance of radioimmunological analysis of blood insulin in diabetes mellitus]Iu E Livergant, K I Krupchitskaia
Voprosy Okhrany Materinstva I Detstva|October 1, 1974
[Blood content of immunoreactive insulin in children and adolescents with obesity]Iu E Livergant, N V Dudenko, K I Krupchitskaia
Problemy Endokrinologii|May 1, 1970
[Some characteristics of sulfhydryl (SH) group levels in serum and thyroid tissue of patients with diffuse toxic goiter]Iu E Livergant, V D Semenov, N G Tsarikovskaia
Meditsinskaia Radiologiia|January 1, 1977
[Effectiveness of the therapeutic use of 125I in diffuse toxic goiter]Iu E Livergant, E D Chebotareva, L N Polishchuk
Meditsinskaia Radiologiia|October 1, 1978
[Cellular immunity indices after radioiodine therapy of thyrotoxicosis]Iu E Livergant, T P Iakimova, V A Duma, et al.
Voprosy Onkologii|January 1, 1979
[State of hypophyseal thyrotropic function in the complex treatment of thyroid cancer]V I Ivanitskaia, A F Vladimirova, Iu E Livergant, et al.
Laboratornoe Delo|January 1, 1978
[Increasing the sensitivity of the radioimmunological determination of thyrotropin by means of blood plasma concentration]Iu E Livergant, A F Vladimirova, I N Lozinskaia, et al.
Vrachebnoe Delo|December 1, 1985
[Central hemodynamics in dust-induced bronchitis in workers in the machine-building industry]S I Rozdil'skiĭ, Iu E Livergant, A I Kleĭner, et al.
Vrachebnoe Delo|December 1, 1975
[Glucose tolerance and content of immunoreactive insulin in patients with ischemic heart disease]Iu E Livergant, V G Teslenko, S V Lebedev, et al.
Pageof 2